Damien Luque Paz

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (8)

Martin Figeac

Université de Lille

Timm Schroeder

Professor for Cell Systems Dynamics

Alain Delmer

Professor of Hematology

Olivier Mansier

University of Bordeaux

Ivan Sloma

Associate professor (MCU-PH)

Sorbonne Université Faculté de Médecine

Valérie Ugo

Hematologie biologique, Prof. MD, PhD

Université d'Angers

Jean-Christophe Ianotto

Chloe James

University of Bordeaux

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Damien Luque Paz

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (8)

Martin Figeac

Timm Schroeder

Alain Delmer

Olivier Mansier

Ivan Sloma

Valérie Ugo

Jean-Christophe Ianotto

Chloe James

Make your next move.

Damien Luque Paz

Research Interests

Explore related searches

Contact this professor

Articles (20)

Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.

Tailored Digital PCR Follow-Up of Rare Fusion Transcripts after Initial Detection through RNA Sequencing in Hematological Malignancies.

Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F-positive myeloproliferative neoplasms.

Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis.

Blood smear invaders: About a fatal case of bacteremia.

CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.

IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.

Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France.

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.

Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms.

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.

JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality.

Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).

Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis.

Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysis.

No detection of atypical one-base deletion of CALR exon 9 with fragment analysis: A molecular trap to avoid.

Myeloproliferative Neoplasms: The Long Wait for JAK2-Mutant Clone Expansion.

Deep learning shows no morphological abnormalities in neutrophils in Alzheimer's disease.

Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation.

Collaborators (8)

Martin Figeac

Timm Schroeder

Alain Delmer

Olivier Mansier

Ivan Sloma

Valérie Ugo

Jean-Christophe Ianotto

Chloe James

Make your next move.